It should be noted that mRNA expression does not necessarily correlate with the protein expression, so we cannot conclude that the ASIC1 and γ-ENaC subunits are really involved in lung adenocarcinoma progression, but the demonstrated phenomenon may point on the existence of a new class of molecular targets for lung cancer therapy. The gene discussed is ASIC1; the disease is lung cancer.